Access cutting-edge plaque psoriasis treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access plaque psoriasis specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related plaque psoriasis treatment provided free
The purpose of this research study is to evaluate the effectiveness and safety of bimekizumab in individuals with moderate-to-severe psoriasis who have failed similar therapies. Bimekizumab improves psoriasis by suppressing a type of substance found in bodies called interleukins (specifically, interleukins 17a and 17F), which are known to increase inflammation. This study will look at the effectiveness of bimekizumab in psoriasis patients that have failed previous therapies that target interleuk
Sponsor: Icahn School of Medicine at Mount Sinai
Check if you qualify for this plaque psoriasis clinical trial in New York, NY
If you're searching for plaque psoriasis treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced plaque psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.